XML 48 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities:    
Net income $ 1,246 $ 339
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Equity in net (income) loss of joint venture (1) 140
Share-based compensation 275 377
Forgiveness of debt 0 (10)
Bad debt (recovery) provision (62) 92
Depreciation and amortization 764 927
Gain on disposal of property, plant and equipment (8) (52)
Changes in assets and liabilities:    
Accounts receivable 454 (432)
Costs and estimated earnings in excess of billings on uncompleted contracts (2,774) (243)
Prepaid expenses and other current assets 203 199
Other assets 13 73
Inventory (67) (22)
Accounts payable and accrued liabilities (980) 892
Deferred revenues (44) (260)
Billings in excess of costs and estimated earnings on uncompleted contracts 107 (330)
Net cash (used in) provided by operating activities (874) 1,690
Cash flows from investing activities:    
Purchases of property, plant and equipment (122) (1,250)
Proceeds from sale of property, plant and equipment 8 72
Cash paid for deposits (290) 0
Cash paid for patents 0 (40)
Cash paid for exclusive product rights 0 (125)
Repayments on notes receivable 3 50
Distribution from joint venture 500 0
Net cash provided by (used in) investing activities 99 (1,293)
Cash flows from financing activities:    
Cash paid for purchase of our common stock 0 (48)
Proceeds from bank term loans 1,021 0
Cash paid for deferred financing costs (45) 0
Repayments of long-term debt (618) (1,223)
Net cash provided by (used in) financing activities 358 (1,271)
Change in cash and equivalents (417) (874)
Cash and cash equivalents, beginning of period 1,523 4,979
Cash and cash equivalents, end of period 1,106 4,105
Supplemental schedule of significant noncash transactions:    
Property, plant and equipment acquired via capital lease 0 1,200
Shares of common stock surrendered by employees related to payroll taxes on vested restricted stock awards $ 34 $ 41